accessibilityalertarrow-downarrow-leftarrow-rightarrow-upchevron-downchevron-leftchevron-rightchevron-upclosedigital-transformationdiversitydownloaddrivedropboxeventsexitexpandfacebookguideinstagramjob-pontingslanguage-selectorlanguagelinkedinlocationmailmenuminuspencilphonephotoplayplussearchsharesoundshottransactionstwitteruploadwebinarwp-searchwt-arrowyoutube

Bratislava, 09 November 2021 – Wolf Theiss has advised KKR, a leading global investment firm, on its investment in Biosynth Carbosynth.

Wolf Theiss, working alongside Sidley, acted as a legal advisor to KKR on its majority acquisition of Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company headquartered in Switzerland.

The Wolf Theiss team was led by Zuzana Hodoňová (Counsel, Bratislava) together with team members Vladimír Šimkovic (Associate, Bratislava) and Dalibor Palatický (Associate, Bratislava).

KKR is a leading global investment firm that offers alternative asset management, capital markets and insurance solutions. KKR agreed to acquire Biosynth Carbosynth, a research products and CDMO services company headquartered in Switzerland from Armira, a Munich-based holding group operating in the investment sector. With the support of KKR, Biosynth Carbosynth plans to accelerate its geographic expansion, broaden its capabilities and expand its product portfolio, further establishing itself as a leader within its chosen markets.

About KKR

KKR is a leading global investment firm that offers alternative asset management and capital markets and insurance solutions. As one of the largest US private equity firms, KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds.

About Biosynth Carbosynth

Biosynth Carbosynth is a Research Products, Life Sciences Reagents and Custom Synthesis and Manufacturing Services Company with operations in Switzerland, the United Kingdom, the U.S., Slovakia and China. The company specialises in carbohydrates, nucleosides, phospholipids, enzyme substrates, antimicrobials, APIs and natural products and has a full range of reagents for protein production and analysis.

Read the full text

Download PDF
9 November 2021

Wolf Theiss advises KKR on its investment in Biosynth Carbosynth

Bratislava, 09 November 2021 – Wolf Theiss has advised KKR, a leading global investment firm, on its investment in Biosynth Carbosynth. Wolf Theiss, working alongside Sidley, acted as a legal advisor to KKR on its majority acquisition of Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company headquartered in Switzerland. The […]...

Read more
5 November 2021

Polish Deal – Surprises for employers and board members

The Polish Deal brings more surprises than the Government’s announcements would suggest. In the Government’s draft changes published last week, there were proposals that will significantly affect employers and Board members – in a negative way, of course.   ...

Read more
4 November 2021

Insolvency law, metrics, & plenary proceedings in Austria

In-depth information on current market conditions and insolvency case developments By Eva Spiegel and Alexander Zollner This detailed overview of insolvency law, metrics and proceedings in Austria provides both practitioners and business readers with a clear picture of the underlying legal framework and policy, along with a sharp picture of ongoing developments in Austria, including […]...

Read more
3 November 2021

Wolf Theiss strengthens its banking and finance team in Bratislava with new hire

Wolf Theiss Bratislava is further expanding. The firm is pleased to announce that Rudolf Pfeffer, who will lead the Bratislava Banking and Finance practice group  is joinning as a Counsel on 2 November 2021. “Rudolf is an experienced, highly reputable banking & finance lawyer with a great personality and under his lead the Bratislava banking […]...

Read more
2 November 2021

Employers in Hungary are now permitted to require vaccination

In response to the 4th wave of the pandemic, the Government Decree 598/2021 (X. 28.) (the “Government Decree“) in Hungary grants employers the right to unilaterally choose to require their employees to be vaccinated against COVID-19.   Employers should take into consideration the following when requiring vaccination: Based on the wording of the Government Decree, […]...

Read more
2 November 2021

Wolf Theiss expands Bucharest office with new partner: Bogdan Bibicu will join the corporate investigations practice

Wolf Theiss welcomes Bogdan Bibicu as its new partner. Bogdan Bibicu will strengthen the Corporate Investigations practice both in Bucharest and throughout the CEE/SEE region. Bogdan brings significant experience in the areas of Corporate Investigations, Banking & Finance, Restructuring & Insolvency, Projects, TMT, Lifesciences & Pharmaceuticals. He will focus on further developing the local investigations […]...

Read more
1 November 2021

Shift in Investments

Keeping pace with evolving markets...

Read more
29 October 2021

Wolf Theiss advises Raiffeisenbank (Bulgaria) EAD on the establishment of its EUR 500,000,000 Euro Medium Term Note Programme

Sofia, 29 October 2021 – Raiffeisenbank (Bulgaria) EAD published the base prospectus for its EUR 500,000,000 Euro Medium Term Note Programme which was approved by the Commission de Surveillance du Secteur Financier of the Grand Duchy of Luxembourg, relying on legal advice from Wolf Theiss’ DCM team, as Issuer’s Bulgarian legal counsel. Wolf Theiss advised […]...

Read more
28 October 2021

Following in the footsteps of Italy: Will the right to work in Romania be conditional upon holding a Covid-19 Green Pass?

A new draft law in Romania prevents access to the workplace absent a Covid-19 Green Certificate. The new measures are applicable during the state of alert for, among others, all employers (public or private) which have offices in buildings where there are more than 50 people at a time. The draft law is a result […]...

Read more
28 October 2021

Do ask, do tell: LGBTIQ+ and the legal industry (Part 2)

Earlier this month, we released our first part of the episode “Do ask, do tell: LGBTIQ+ and the legal industry ” with a focus on sexual orientation, gender and the role of diversity at Wolf Theiss. Also in this episode, we welcome Christian Mikosch, Partner of our Corporate/M&A team at Wolf Theiss and Pride Biz […]...

Read more
22 October 2021

Wolf Theiss advises Banca Comercială Română S.A. on its inaugural RON 500 million Senior Preferred Green Notes

Wolf Theiss acted as legal advisor to Banca Comercială Română S.A. in relation to its inaugural issue of the RON 500 million 5.00 per cent Senior Preferred Green Notes due in 2028 under its Multi Issuer EMTN Programme. On 14 October 2021, Banca Comercială Română S.A. successfully closed its first issue of Senior Preferred Green […]...

Read more
21 October 2021

The Future of Mobility

Since man first traveled to the moon half a century ago, the technology behind mobility has taken many giant leaps forward. Has it advanced enough to allow us to explore Mars effectively? Back on Earth, the trend goes towards more autonomous vehicles? How safe is autonomous driving and who is responsible? And what about drones? […]...

Read more